As per MarkNtel Advisors The Global Radiopharmaceuticals Market size was valued at around USD 7.11 billion in 2024 and is projected to reach USD 12.73 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.19% during the forecast period, i.e., 2025-30. 

Global Radiopharmaceuticals Market Systems Market Outlook:

The Russian Seed Market is rapidly evolving, driven by agricultural modernization, government reforms, and technological advancements. A key growth engine is the federal “Land” initiative, which aims to bring 13 million hectares of unused land into cultivation by 2030. This large-scale modernization effort is promoting the use of high-yielding, high-quality seed varieties to boost productivity and meet both domestic and export demands.

Explore the Insights – Download a Free Sample:  https://www.marknteladvisors.com/query/request-sample/radiopharmaceuticals-market.html

Global Radiopharmaceuticals Market Systems Market Segmentation:

By Radioisotope

-Technetium 99- Market Size & Forecast 2020-2030, USD Million

-Fluorine 18- Market Size & Forecast 2020-2030, USD Million

-Iodine 131- Market Size & Forecast 2020-2030, USD Million

-Gallium 68- Market Size & Forecast 2020-2030, USD Million

-Iodine 123- Market Size & Forecast 2020-2030, USD Million

-Others (Yttrium 90, Indium 111, etc.)- Market Size & Forecast 2020-2030, USD Million

By Indication

-Oncology- Market Size & Forecast 2020-2030, USD Million

-Cardiology- Market Size & Forecast 2020-2030, USD Million

-Gastroenterology- Market Size & Forecast 2020-2030, USD Million

-Nephrology- Market Size & Forecast 2020-2030, USD Million

-Others (Neuroendocrinology, Neurology, etc.)- Market Size & Forecast 2020-2030, USD Million

By Type

-Diagnostic- Market Size & Forecast 2020-2030, USD Million

-Therapeutic- Market Size & Forecast 2020-2030, USD Million

By End User

-Hospitals- Market Size & Forecast 2020-2030, USD Million

-Medical Imaging Centers- Market Size & Forecast 2020-2030, USD Million

-Others (Specialty Clinics, Research Organizations, etc.)- Market Size & Forecast 2020-2030, USD Million

By Region

-North America

-South America

-Europe

-The Middle East & Africa

-Asia-Pacific.

Report Delivery Format – Market research reports from MarkNtel Advisors are delivered in PDF, Excel, and PowerPoint formats. Once the payment is successfully processed, the report will be sent to your registered email within 24 hours.

Comprehensive Analysis: Preview detailed market analysis, including segmentation, competitive landscape, and Geographical insights – https://www.marknteladvisors.com/research-library/radiopharmaceuticals-market.html

Global Radiopharmaceuticals Market Driver:

Increasing Prevalence of Chronic Diseases – There are a large number of patients with cardiovascular diseases globally due to factors, such as changing lifestyles, obesity, an aging population, improved survival rates from heart attacks and strokes, etc. For instance, the British Heart Foundation stated in 2024 that, around 620 million, which makes 1 in 13 people, are living with heart and circulatory diseases across the world.

With that, the adoption of radiopharmaceuticals to perform diagnosis and risk assessment and to monitor the influence of therapies on heart conditions is witnessing growth, propelling the overall Radiopharmaceuticals Market. Also, the prevalence of cancer is increasing across the globe and this is expected to drive the demand for radiopharmaceuticals

Report Highlights Essential Insights for Strategic Decision-Making

• Detailed market size, share, and forecast analysis
• In-depth pricing trends and segment-wise cost evaluations
• Key industry strategies, including innovation, partnerships, and acquisitions
• Critical value chain analysis and stakeholder profiling
• Regional import-export market insights and trade flow assessment
• Thorough competitive benchmarking of top hearing aid manufacturers
• Identification of new growth opportunities and niche market segments
• Overview of market trends, drivers, and challenges shaping future demand

Some of the leading players in the Global Radiopharmaceuticals Market are:

Bayer AG, Iso-Tex Diagnostics, Inc., Jubilant Pharmova Limited, Novartis AG, General Electric Company, Lantheus Holdings, Inc., Eli Lilly and Company, Siemens Healthineers AG, Curium Pharma, Cardinal Health, Blue Earth Diagnostics, Inc. (Bracco Group), Acrotech Biopharma, Northstar Medical Technologies LLC, IBA Radiopharma Solutions, Sun Pharmaceutical Industries, Inc.

Research Methodology Summary

A systematic approach is used to ensure accurate market insights, combining both bottom-up and top-down methods. Data triangulation validates findings from multiple angles.

Select a License That Matches Your Business Requirements with Instant Offer –Related Reports: https://www.marknteladvisors.com/pricing/radiopharmaceuticals-market.html

Global Water Pumps Market Research Report: Forecast (2025-2030) - https://www.marknteladvisors.com/research-library/global-water-pumps-market.html

https://www.marknteladvisors.com/research-library/latin-america-irrigation-water-pumps-market.html

https://www.marknteladvisors.com/research-library/egypt-domestic-water-pump-market.html

https://www.marknteladvisors.com/research-library/mena-centrifugal-water-pumps-market.html

https://www.marknteladvisors.com/research-library/india-water-purifier-market.html

About us

MarkNtel Advisors is a globally recognized market research and consulting firm delivering intelligence across the healthcare industry, spanning pharmaceuticals, medical devices, healthcare IT, and biotechnology. Our analysts combine domain expertise with innovation tracking to help healthcare organizations improve efficiency and patient outcomes. Through Consulting Services, we assist clients in interpreting insights, designing go-to-market strategies, and adapting to regulatory changes, fostering sustainable growth in the evolving global healthcare ecosystem.

or media inquiries, or further information, please reach out to:

MarkNtel Advisors
Email: [email protected]
Phone: +91 8719999009
Website: www.marknteladvisors.com